Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression-Free-Survival”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04741438
What this trial is testing

Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

Who this might be right for
Sarcoma
Centre Leon Berard 96
Testing effectiveness (Phase 2)UnknownNCT04102982
What this trial is testing

Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer

Who this might be right for
NSCLC Stage IV
Shandong Provincial Hospital 200
Large-scale testing (Phase 3)Study completedNCT01191060
What this trial is testing

Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years

Who this might be right for
Myeloma
University Hospital, Toulouse 700
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Large-scale testing (Phase 3)Ended earlyNCT01200212
What this trial is testing

Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 432
Large-scale testing (Phase 3)Active Not RecruitingNCT05155254
What this trial is testing

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

Who this might be right for
Metastatic MelanomaUnresectable Melanoma
IO Biotech 407
Not applicableUnknownNCT03336554
What this trial is testing

Epigenetic Biomarker for Osteosarcoma

Who this might be right for
Histologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORRProgression-free Survival, PFS+1 more
Peking University People's Hospital 100
Not applicableActive Not RecruitingNCT06900283
What this trial is testing

Quality of Life as a Predictor of OS and PFS in Patients With Lung Cancer

Who this might be right for
Lung CancersLung Cancer, Non-Small Cell
Instituto Nacional de Cancerologia, Columbia 320
Large-scale testing (Phase 3)Study completedNCT01073865
What this trial is testing

Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 222
Large-scale testing (Phase 3)Study completedNCT00391092
What this trial is testing

Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 424
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Large-scale testing (Phase 3)UnknownNCT05178628
What this trial is testing

The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Michalis Karamouzis 450
Testing effectiveness (Phase 2)Study completedNCT00658437
What this trial is testing

CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy

Who this might be right for
Melanoma
Cytavis Biopharma GmbH 31
Testing effectiveness (Phase 2)Study completedNCT04156087
What this trial is testing

Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Baki Topal 12
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableUnknownNCT04456855
What this trial is testing

Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients

Who this might be right for
Breast Neoplasm FemaleSurgeryAdvanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 358
Testing effectiveness (Phase 2)Looking for participantsNCT06594926
What this trial is testing

Working Out M0 Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Early research (Phase 1)Looking for participantsNCT06487481
What this trial is testing

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma (ACC)Recurrent Adrenocortical Carcinoma (ACC)Recurrent Abdominal Adrenocortical Carcinoma (ACC)+2 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)UnknownNCT00643825
What this trial is testing

Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients

Who this might be right for
Glioblastoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 64
Not applicableLooking for participantsNCT05299840
What this trial is testing

Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Oncomedics 450
Next Page